.Merck & Co.'s TIGIT program has actually suffered yet another problem. Months after shuttering a...
.After a year described through pipeline cuts, the shift of its CEO and also discharges, Exscientia ...
.Cullinan Rehab was actually thrilled sufficient along with Harbour BioMed's bispecific immune syste...
.Within this full week's incident of "The Top Pipe," our company're diving in to Strong Biotech's ye...
.The confetti is still flying coming from Eli Lilly's celebration celebrating the commendation of Al...
.Accept to today's Chutes & Ladders, our roundup of considerable leadership hirings, shootings an...
.Complying with a poor presenting for Lykos Rehabs' MDMA prospect for trauma at a latest FDA consult...
.AN2 Rehabs is actually reassessing its own service in feedback to poor midphase records, swearing t...
.Merck & Co. is actually paying for $700 thousand upfront to test Amgen in a blood cancer market....
.With Gilead Sciences almost an FDA choice for its own liver disease medicine seladelpar, the provid...